What question did this study set out to answer?

To determine the seroprevalence of measles IgG antibodies among children in Ireland.

March 8, 2026EurosurveillanceOpen Access

Cross-sectional seroprevalence study of measles antibodies among children to identify gaps in population immunity, Ireland, 2024

View Full Paper

Ask AI

Bookmark

Authors

Cross-sectional study found 90.3% measles IgG seroprevalence in children, indicating gaps in immunity for older age groups.

To determine the seroprevalence of measles IgG antibodies among children in Ireland.
Conducted a cross-sectional seroprevalence study from February to June 2024.
Utilized convenience sampling of anonymised residual serum samples from four hospital laboratories.
Tested samples for measles IgG antibodies using a chemiluminescence immunoassay.
Adjusted seropositivity rates for test sensitivity and specificity.
Out of 2,924 samples, 2,509 were seropositive, indicating a seroprevalence of 90.3%.
Higher seropositivity observed in ages 3-9 years compared to 10-17 years.
Children aged 3-5 years had 94.9% seropositivity and those aged 10-13 years had 89.1%.
Suboptimal immunity (< 95%) was found among children aged 10-17 years.

Brady et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

March 8, 2026EurosurveillanceOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Cross-sectional study found 90.3% measles IgG seroprevalence in children, indicating gaps in immunity for older age groups.

To determine the seroprevalence of measles IgG antibodies among children in Ireland.
Conducted a cross-sectional seroprevalence study from February to June 2024.
Utilized convenience sampling of anonymised residual serum samples from four hospital laboratories.
Tested samples for measles IgG antibodies using a chemiluminescence immunoassay.
Adjusted seropositivity rates for test sensitivity and specificity.
Out of 2,924 samples, 2,509 were seropositive, indicating a seroprevalence of 90.3%.
Higher seropositivity observed in ages 3-9 years compared to 10-17 years.
Children aged 3-5 years had 94.9% seropositivity and those aged 10-13 years had 89.1%.
Suboptimal immunity (< 95%) was found among children aged 10-17 years.

Brady et al. (2026) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark